Brief: Oric Pharmaceuticals Provides Corporate Update
09/01/2023 13:28
Jan 9 (Reuters) - Oric Pharmaceuticals Inc ORIC.O :
* ORIC PHARMACEUTICALS PROVIDES CORPORATE UPDATE AND
HIGHLIGHTS
KEY UPCOMING MILESTONES
* ORIC PHARMACEUTICALS INC - CASH AND INVESTMENTS OF $228
MILLION
EXPECTED TO FUND OPERATING PLAN INTO FIRST HALF OF 2025
* ORIC PHARMACEUTICALS INC - INITIAL PHASE 1B DATA FOR THREE
ONGOING CLINICAL TRIALS EXPECTED IN SECOND HALF OF 2023
Source text for Eikon: ID:nGNXW3zqm
Further company coverage: ORIC.O
((reuters.briefs@thomsonreuters.com;))
Recent news on ORIC Pharmaceuticals
See all newsBrief: Oric® Pharmaceuticals Announces Agreement With Cancer Research UK
ORIC Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: ORIC Pharmaceuticals Q1 Operating Expenses USD 39.619 Million
Brief: Oric Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ORIC Pharmaceuticals Q4 loss narrows